Table 4. Transduction of Primary Human... | American Society of Hematology

Table 4.

Transduction of Primary Human B-Precursor ALL Cells With Retroviral and Lentiviral Vectors

Experiment No.^4-150	Patient No.	MOI	% Cells Expressing EGFP
Experiment No.^4-150	Patient No.	MOI	MLV-CMV-EGFP	PHR′-CMV-EGFP
1	1	30	2.75	2.2
		300	25.69	18.34
	2	30	2.81	2.35
		300	21.71	19.44
2	1	3,000	8.11	28.68
	3	3,000	19.55	29.1
3	1	100	31.08	5.03
		500	61.29	15.47
	3	100	48.09	9.57
		500	74.05	15.28
4	4	3,000	14.53	43.35
	5	3,000	4.09	34.92

Experiment No.^4-150	Patient No.	MOI	% Cells Expressing EGFP
Experiment No.^4-150	Patient No.	MOI	MLV-CMV-EGFP	PHR′-CMV-EGFP
1	1	30	2.75	2.2
		300	25.69	18.34
	2	30	2.81	2.35
		300	21.71	19.44
2	1	3,000	8.11	28.68
	3	3,000	19.55	29.1
3	1	100	31.08	5.03
		500	61.29	15.47
	3	100	48.09	9.57
		500	74.05	15.28
4	4	3,000	14.53	43.35
	5	3,000	4.09	34.92

CD40L was used in experiments no. 1 and 2.